Aillis Company
Aillis specializes in the development of testing methods for Influenza using artificial intelligence technology.
Technology:
Artificial Intelligence, Information Technology, Medical
Industry:
AI
Headquarters:
Tokyo, Tokyo, Japan
Founded Date:
01.11.2017
Employees Number:
11-50
Funding Status:
Early Stage Venture
Investors Number:
6
Total Funding:
11336223
Last Funding Date:
06.08.2020
Last Funding Type:
Series B
Register and Claim Ownership